Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single-dose GZR4
Status:
COMPLETED
Trial end date:
2023-03-24
Target enrollment:
Participant gender:
Summary
This trial is conducted in China. The aim of this trial is to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single-dose GZR4.